Pfizer Inc PFE

PFE PERFORMANCE ANALYSIS BY FORBES

[Humanist]

After The Recent 4% Fall Will Pfizer Stock Rebound To Make Fresh Highs?

https://www.forbes.com/sites/greatspeculations/2021/08/26/after-the-recent-4-fall-will-pfizer-stock-rebound-to-make-fresh-highs/?sh=3d90f54f5db0
 
Aug 26, 2021,09:00am EDT|3,785 views
 
 
23 January 2021, Berlin: Pfizer's logo is displayed at one of its corporate offices. Since 2020, ... [+]
 DPA/PICTURE ALLIANCE VIA GETTY IMAGES
[Updated: 8/26/2021] PFE Stock Decline
The stock price of Pfizer (NYSE: PFE) reached an all-time high of $52 last week before a recent sell-off in Covid-19 vaccine stocks drove PFE down to its current level of around $48. PFE stock has fallen 4% over the last five days. The decline was seen in other Covid-19 vaccine stocks as well, including Moderna and Novavax. There is no announcement or development that should warrant any concern. The decline appears to be profit-booking at the higher levels. PFE stock has moved over 30% year-to-date. The figure is actually big for a large-cap pharmaceutical company. For perspective, Merck MRK -0.3% moved barely 1% while other large pharmaceutical stocks, such as Johnson & Johnson JNJ -0.3%, Roche, and Bristol Myers Squibb BMY -0.5% have moved around 12% each. But will PFE stock continue its downward trajectory over the coming weeks, or is a recovery in the stock imminent?

According to the Trefis Machine Learning Engine, which identifies trends in the company’s stock price using ten years of historical data, returns for PFE stock average around 3% in the next one-month (twenty-one trading days) period after experiencing a 4% drop over the previous week (five trading days).

Furthermore, Pfizer’s PFE -1.5% Covid-19 vaccine has received full U.S. FDA approval earlier this week. While the shot is being distributed on an emergency use basis currently, a full authorization may encourage more people who were previously on the fence about getting vaccinated to finally take the shot. Moreover, having a fully approved vaccine could possibly enable businesses to require mandatory vaccinations. This could lead to incrementally higher demand for Pfizer’s vaccine. Our Pfizer vaccine updates has more details. We believe that PFE stock will likely rebound after its recent fall, and continue to make fresh highs in the near term

But how would the returns fare if you are interested in holding Pfizer stock for a shorter or a longer time period? You can test the answer and many other combinations on the Trefis Machine Learning Engine to test Pfizer stock chances of a rise after a fall. You can test the chance of recovery over different time intervals of a quarter, month, or even just 1 day!

MACHINE LEARNING ENGINE – try it yourself:
IF PFE stock moved by -5% over five trading days, THEN over the next twenty-one trading days PFE stock moves an average of 3%, with a 62% probability of a positive return over this period.